Lv1
60 积分 2025-07-30 加入
Prediction of creatinine clearance from serum creatinine
2天前
已完结
Claudin 18.2 as a novel therapeutic target
22天前
已完结
Eosinophilic pleocytosis in the cerebrospinal fluid following CAR-T cell therapy for central nervous system lymphoma: A case for warning?
24天前
已关闭
Optimizing real-world outcomes in high-risk relapsed/refractory (r/r) DLBCL with CAR T cell therapy: A vodcast and case example
25天前
已完结
Use of dasatinib for the treatment of refractory immune effector cell-associated neurotoxicity syndrome after axicabtagene ciloleucel infusion: A case report
25天前
已完结
Role of procalcitonin, C-reactive protein and ferritin in cytokine release syndrome after CAR T-cell therapy in children and young adults
26天前
已完结
Severe hypophosphatemia following idecabtagene vicleucel regardless of the severity of cytokine release syndrome
26天前
已完结
T-cell malignancies following CAR T-cell therapy: Insights from the FDA adverse event reporting system (FAERS)
26天前
已完结
Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: The ZUMA-12 study
26天前
已完结
CD19 directed CAR T therapy for transformed follicular lymphoma: A CIBMTR analysis
1个月前
已完结
皖公网安备34019202002308
